Interleukin-3 Receptor Subunit Alpha Positive
2 clinical trials · Condition
◉ Watch Interleukin-3 Receptor Subunit Alpha Positive
| Record | Firm | Date |
|---|---|---|
| Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer (NCT03739606) | City of Hope Medical Center | 2020-10-20 |
| Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT02159495) | City of Hope Medical Center | 2015-12-15 |
Track Interleukin-3 Receptor Subunit Alpha Positive automatically
Every clearance here is in the API, with alerts when new ones post.